数据日期 2026-10-29 · 生成时间 2026-10-29 06:03
证据级别：摘要级。本条依据 PubMed 结构化摘要与元数据撰写，付费墙全文未获取、未逐节核验，本站未做任何数值推算补全。
研究问题
Alzheimer's disease (AD) is a neurodegenerative disorder driven by β-amyloid (Aβ) deposition, neuroinflammation, oxidative stress and metabolic dysregulation, with the latter as a central pathological hub. hucMSC-derived exosomes (hucMSC-exosomes) show therapeutic potential for AD, but their metabolic remodeling mechanisms remain unclear.
方法
We combined behavioral tests, pathological assays and untargeted metabolomics to investigate the neuroprotective effects and mechanisms of hucMSC-exosomes in APP/PS1 AD mice.
核心结论
Seven-month-old male APP/PS1 mice were randomly divided into AD-vehicle and AD-hucMSC-exosome groups, with age-matched C57BL/6 mice as wild-type controls.；All mice received tail vein injections for 6 weeks.；Morris Water Maze tests revealed that hucMSC-exosomes significantly improved spatial learning and memory in AD mice.；Pathological analyses confirmed that hucMSC-exosomes reduced cerebral Aβ deposition, suppressed hippocampal pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and restored antioxidant capacity (SOD, GPx, GSH/GSSG). ‖ 结论：Collectively, hucMSC-exosomes ameliorate AD pathological phenotypes and cognitive deficits, an effect accompanied by metabolic homeostasis remodeling through cascades of reduced Aβ deposition, suppressed neuroinflammation and alleviated oxidative stress.
局限
未能获取全文，具体设计细节、失访与统计学处理无法核验。
对本项目的价值
★★★☆☆ 脑老化是最大未满足需求，也是终点最难量化的领域；biomarker 与认知读数选择最敏感。
原文题录
- 英文标题：hucMSC-derived exosomes rescue cognitive impairment and Alzheimer-like pathology in APP/PS1 mice via metabolic remodeling.
- 期刊与标识：Exp Neurol · PMID 42946034 · DOI 10.1016/j.expneurol.2026.116100**
B 级证据分级：B 级（同行评议临床前研究，主要为动物模型）
本文核心结论来自动物模型或体外细胞学，属临床前证据，不能外推至人体。「延长健康寿命」「改善功能」等表述在小鼠中的意义，与人类临床结局之间仍有距离。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」（SOP §4.2 摘要级）撰写，依据期刊公开摘要与 PubMed 元数据；付费墙全文未获取之处已标注「待补全文」，未做任何数值推算补全。